Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
I totally agree. Trinityman has succeeded in eloquently accentuating the positive aspects of being invested in Synairgen. Thank you so much for that summary. It arrived at just the right time.
Recently , I had also carefully examined all the pros and cons of being invested. The last thing I need is any advice on adopting a more cautious approach. I gave myself that advice over a year ago, when my net worth reached an all time pinnacle. My thoughts were leaning towards selling everything, and investing in FTSE 100 stock which were still at lows at that time. By today that strategy would have given very good returns. Instead, I held my Synairgen stock through what turned out to be a rollercoaster ride. Additionally, I bought and sold other stocks - always at a profit. Currently, I am back at a pinnacle, but have an opinion that I am only getting started with Synairgen. I share the optimism expressed by Oakleaf and the Telegram Group. This investment is very close to coming to fruition. Very soon, I suspect that there may well be a number of contented investors contributing to this board.
Finally, I agree with the recent opinions expressed about Synairgen’s reformatted website. It is as good as I have seen anywhere. A website fit for a company set for a significant upward trajectory.
My best wishes to all patient long term Synairgen investors.
Why has so much scepticism arisen on this board? Contributors have tirelessly uncovered scientific evidence supporting the case for Synairgen over the last 20 months. Polygon are probably continuing to increase their percentage ownership of the company as I write. Since I have been invested, there hasn’t been a single opponent of Synairgen who has produced an argument which would lead me to part with my any of my stock. It is high time for some contributors to lighten up, and look back of the huge vault of positive information that has constantly featured on this board over 18 months.
On the subject of negativity, Sir John Bell wrote in today’s Spectator that the EU may be responsible for a very large number of Covid related deaths owing to their opposition to the AZ vaccine. Has anyone asked him the question as to how many deaths that our Government advisors are responsible for because of their dismissive attitude towards Synairgen during the early stages of the pandemic?
This is not a forum in which I need to justify my long-term optimism concerning Synairgen’s prospects. The mountain of reliable evidence for future success is irrefutable. Any dissenters have not produced a shred of tangible evidence to the contrary.
I fully understand the “nervousness” shown by some. I see it as a case of preparing for the worse, although there is nothing to suggest that the best isn’t yet to come. On the basis of yet more positive reinforcement from Polygon, I hope that it will literally be a case of onwards and upwards as the Sprinter trial outcomes grow increasingly closer.
The Friday fomo, which has prevailed until now seems to have gone away this week. It would not surprise me to see the share price closing at the last placement price (175p), or lower, this afternoon. In my view, this is creating a false illusion. A high proportion of Synairgen shares are now in safe hands. No sensible long-term holder, whose average buy in price is considerably lower than the current share price, is going to risk trading this share any more, as the Sprinter results really are imminent.
Consequently, the share pool currently being traded is relatively small. The major business is done, although confident long term retail investors are topping up at today's unexpected low prices. There is no point in undertaking a fallacious calculation as to how much the value of my holding has decreased since the pre- Christmas closing price. One thing is certain in my case. Win or lose, this will be my final long-term investment. As someone commented recently it has been a long rollercoaster ride.
I was surprised to read recently that Microsoft were prepared to spend $67B to buy out a company specialising in computer games. Perhaps it is my age, but I sometimes think that I have stepped into an alternate reality which makes little sense?
By comparison, most Synairgen investors would be ecstatic if a buyout emerged for a tenth of the value of the aforementioned elite games company.
Currently, the share price has maintained a steady level for over a week. There has been little news, and comments on bulletin boards have stopped.
I am optimistic about this company’s future prospects. The most recent communication from the CEO suggests that developments will be forthcoming. It will be reassuring to find some signs that IB are moving forward with their plans. I am impressed with the rhetoric, but it is time for the company to “walk the talk”.
Yesterday, I offered an opinion that the analysis of the Sprinter results was taking longer than I had anticipated. The “number crunching”, and the summary and conclusions aspects are probably mostly completed by now, but there is a lot more for the company to think about.
The comments offered in yesterday’s threads here have led me to think deeper about the situation. There is more to do in producing the initial RNS, followed closely by a host of other information than I had originally perceived. I trust the company to get this right. The Synairgen “launch”, when it happens, will be well worth the wait.
Agreed Docdaneeka.
I trust Richard Marsden’s judgement on this one. He has been working tirelessly on this for so long. One of his stated objectives is to achieve the optimum value for investors. Your description of a possible endgame is realistic, and it will be interesting to observe the post-results scenario. Having waited for so long, no serious long term investor will be in any rush to press the sell button too soon.
Regards and good wishes.
Hi Andybe4.
You are right in they have always been somewhat “Bernese” in getting things done in the past. However, this time around there is a big team of highly respected professionals processing the data and working on presentation strategies.
I am not impatient, but surprised by the fact that it is taking so long. I worked in scientific research for many years. Writing papers takes time within a small team. As previously stated, Synairgen is a very professional company with the necessary resources and personnel to get a high level piece of work completed in good time. For the time being I will stay with my “takeover” theory. Meanwhile, it will continue to take as long as the company deems to be appropriate.
Regards and good wishes.
Thank you for doing that. Good to have it further confirmed that the company is getting on with the promised initiatives, and transactions. We will have those RNS statements soon enough.
Regards and good wishes.
Hi Bouchos.
Unfortunately, these sad uninvested individuals have nothing better to do their time. They are best ignored, or filtered. (Having said that, I have just reported another specimen on a different board; they get to us all sometimes.)
Meanwhile, I continue to anticipate positive developments here, although I have no idea when the anticipated information will arrive.
Regards, and good wishes.
I am not concerned about the current share price action, which at this late stage prior to a significant announcement is irrelevant. I am however puzzled at the time that it is taking to analyse and publish the Sprinter results. When I consider the time line, there is no doubt in my mind that there has already been sufficient time for the latter. Many will argue otherwise, and I will not disagree, as it is my opinion more based on past experiences than anything else.
The sample size is not large. There is a world class team of specialists available at the company, and the data gathering and “number crunching” has been contracted out to a highly respected company. On that basis, I expected the processing time prior to an announcement to be swift and efficient.
The last time I encountered a situation with no tangible information from a company, and a slowly declining share price over a period of months, it was followed by an abrupt buyout. The longer that this situation lingers, the more inclined I am to believe that we there will be a similar outcome here.
I am not impatient. Every company has its own methods of achieving outcomes, and it will take as long as is required for the company to be ready to make an announcement, and process its consequences. With each passing day, my thoughts are drifting towards a takeover when all these deeds are done.
Good fortune to all Synairgen holders. The above is merely my opinion, with nothing substantive to validate it. I will not engage in any dialogue over this, and would be equally happy whatever post results path that Synairgen may choose to take.
BigjohnnyWin. I have similar aspirations. I need 500p per share to complete on a property project, set up a dividend portfolio, and make a substantial charitable donation. I would favour a buyout, as I really don't have much of an idea as to the actual future value of my investment.
In the recent past, I have both sold too early, and sold too late to secure the optimum profit on three consecutive smaller investments. It is interesting to reflect that all three, for different reasons, are now worth considerably less than my sell prices. It is going to be a difficult time for all Synairgen investors when the anticipated good news arrives. I will probably sell if I achieve the sum needed for my aspirations. In my view, the most important aspects of life are long term financial stability, good health, and happiness. 500p per share would finally fulfil the first aspect; I am fortunate to have been blessed with the more important second and third aspects throughout my life.
Regards and good wishes.
A Beatle song, but also a metaphor for my Synairgen investment. I have been invested at my current level without further buying or selling for fifteen months. I am currently well in profit.
Richard Marsden once said that Synairgen was an investor’s share. By this, he probably meant that the company is well undervalued when compared with its future potential value. I agreed with him at the time, and still do.
I failed to recognise the fact that it would also turn out to be a prolific trader’s shares. Fortunes have been made on multiple occasions as I have continued to hold. At my level of investment, I did not want to engage in trading activity for fear of missing out. Paradoxically, I did miss out on making a lot of profit through simple trading activity. Fortune has indeed favoured the brave in that respect. I also accept that one has to understand the effects and consequences of market triggers to facilitate the process. It is easy to reflect in hindsight on what might have been, but scary to engage in this activity without knowing what lies ahead.
I am happy with my strategy to date, but look forward to a significant RNS from the company, which will hopefully be the start of a sequence in which long term holders are rewarded for their patience. Nothing is as yet assured, but I am as confident as I can be that this journey will end with a good measure of success, whichever path the company chooses to take following the Sprinter results announcement.
Thank you "Pondering" for your balanced assessment of the situation, from an investor's point of view. It would seem that the company's business model is more complex than early investors were led to believe.
As an investor of some four months standing, I am in a less precarious position than many, but am down in the value of my stock when compared with my invested capital. Like many sincere contributors to this board, I believe that news of anticipated developments is, by now, overdue in relation to earlier comments from the company. However, there is little to be done about it except to hold, and wait and see in my case. Others, based on their own assessment will no doubt subscribe to different courses of action.
Regards.
I fail to understand the mentality of individuals, who contribute disparaging comments about a company on its bulletin board - several times a day?
Investors have purchased stock based on their own understanding , presumably on the basis of their research? Are investors going to pay attention to nameless individuals, who too often express themselves in an inappropriate manner? Somehow, I think not.
Should these individuals have anything of value to add, positive or negative, I would be the first to thank them. Sadly, they seem to be aimless people, with nothing better to do than write complete nonsense about a company in which they have nothing invested.
I still believe, on the basis of my research, that this company will eventually deliver on its promises. However, it is apparent that we shall need to be patient until the anticipated news is finally announced.
Is today the day of the SYME de-ramping trolls AGM? They seem to have agreed to meet up on this board this morning. They are wasting their time, as few investors read their contributions.
On that subject, how many of us read the contributions of others thoroughly? I was severely criticised yesterday, apparently by a SYME investor, who thought that I was in collusion with the nefarious TW. Had he/she read the post thoroughly, it would have been obvious that I am invested.
My lesson learned is never to complain about the company’s lamentable communication, and poor delivery, - on this board. It attracts unpleasant attention from some frustrated SYME investors. Henceforth, I will try and supply positive information as and when I find it. By inference, my posts will be few and far between until the anticipated positive information finally arrives.
My best wishes to all SYME investors, especially those of you who have held for the long term. Our day will come, for sure.
Not THE anticipated RNS, but a solid start to the day. The share price pattern has not followed the increase from “fomo” buying that I was expecting in January.
With THAT RNS one day closer, and a recent flow of very positive information, perhaps the share price will finally move to the recent 200+p highs and beyond. Surely the time for celebration is now “imminent”.
(I expect that I will henceforth I will always associate that last word with Synairgen.)
Why would an individual spend so much time on a bulletin board synthesising fallacious arguments to contradict the massive repository of evidence supporting the eventual success of Synairgen? The flow of positive supportive information has continued to amass in the eighteen months that I have been invested.
His /her reasons for constantly disseminating such weak low-level arguments is puzzling? Presumably he/she must have his/her reasons? Without doubt he/she will disappear never to return within the next month.
GardaBellissimo6.
What an odd way to celebrate a 19% increase in share price? You will no doubt find other means of spinning away the big share price increases when the anticipated positive announcements finally arrive?
Regards.